Revenue: The sum of all revenue fields included for a company's operating activities.
Northwest Biotherapeutics, Inc. (NWBO) had Revenue of $0.67M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$0.67M |
$1.25M |
|
-- |
|
$0.67M |
|
$14.18M |
|
$-13.50M |
|
$14.36M |
|
$0.85M |
|
$0.85M |
|
$1.39M |
|
$1.39M |
|
$1.39M |
|
$1.39M |
|
$-13.50M |
|
$-12.16M |
|
1.46B |
|
1.46B |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$5.52M |
|
$17.41M |
|
$75.77M |
|
$81.29M |
|
$91.70M |
|
$0.33M |
|
$37.16M |
|
$128.86M |
|
$-60.28M |
|
$-101.38M |
|
$-47.57M |
|
1.56B |
|
| Cash Flow Statement Financials | |
$-44.76M |
|
$-1.81M |
|
$49.33M |
|
$2.17M |
|
$3.04M |
|
$0.86M |
|
$1.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.06 |
|
-- |
|
-- |
|
-0.01 |
|
-1.09 |
|
100.00% |
|
-2009.52% |
|
-2009.52% |
|
-- |
|
126.64% |
|
186.16% |
|
$-46.27M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-2.30% |
|
-1.37% |
|
1.71% |
|
-2.94% |
|
$-0.03 |
|
$-0.03 |
|
$-0.03 |
|